Verrica Pharmaceuticals Shares Are Trading Lower After the Company Announced a Structuring to Reduce Costs and Expand Access to YCANTH for the Treatment of Molluscum Contagiosum. Also, Brookline Capital Downgraded the Stock From Buy to Hold.
Verrica Pharmaceuticals Shares Are Trading Lower After the Company Announced a Structuring to Reduce Costs and Expand Access to YCANTH for the Treatment of Molluscum Contagiosum. Also, Brookline Capital Downgraded the Stock From Buy to Hold.
verrica制药股价下跌，公司宣布进行结构调整以降低成本并扩大YCANTH治疗软疣的途径。此外，Brookline Capital将股票评级从买入调整为持有。
Verrica Pharmaceuticals Shares Are Trading Lower After the Company Announced a Structuring to Reduce Costs and Expand Access to YCANTH for the Treatment of Molluscum Contagiosum. Also, Brookline Capital Downgraded the Stock From Buy to Hold.
verrica制药股价下跌，公司宣布重组以降低成本并扩大对YCANTH治疗软疣的获取。此外，Brookline Capital将股票评级从买入调整为持有。
资讯热榜
更新时间